UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000005617
Receipt No. R000006629
Official scientific title of the study Biological assessment for brain tumors in 5-ALA-induced fluorescence-guided surgery
Date of disclosure of the study information 2011/05/20
Last modified on 2018/11/22 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Biological assessment for brain tumors in 5-ALA-induced fluorescence-guided surgery
Title of the study (Brief title) Fluorescence-guided surgery for brain tumors
Region
Japan

Condition
Condition Brain tumors
Classification by specialty
Neurosurgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 This report analyzed relationships among histology,
radiological findings, and 5-ALA-induced fluorescence, using surgical specimens obtained with navigation-guided stereotactic biopsy. The present study aimed to reveal the tumor characteristics relating with 5-ALA-induced fluorescence, in order to refine glioma resection using these techniques.
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Histological findings of surgical specimens and 5-ALA induced fluorescence
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Medicine
Interventions/Control_1 Oral administration of 5-ALA
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who meet all of the requirements described below are includesd.
1. Patients who are hospitalized in order to undergo surgery.
2. Patients whose preoperative diagnosis is glioma, meningioma or metastatic brain tumor.
3. Patients who provide a written informed consent.
Key exclusion criteria Patients who meet any of the conditions described below are excluded.
1. Patients with hypersensitivity to 5-ALA or porphyrins.
2. In case of known or suspected pregnancy, or women who are breast-feeding.
3.In case of known or suspected acute or chronic types of porphyria.
4. In case of renal insufficiency (serum creatinine is more than 2.0mg/dl)
5. In case of hepatic insufficiency (serum gamma glutamyl transpeptidase >100IU/l, ptotronbin time <60% or total bilirubin >3mg/dl)
6. In case of other conditions considered as undesirable for entry in this clinical trial.
Target sample size 75

Research contact person
Name of lead principal investigator Naoya Hashimoto
Organization Osaka University Hospital
Division name Department of Neurosurgery
Address 2-15, Yamadaoka, Suita, Osaka 565-0871, Japan
TEL 0668793652
Email hashimotonaoya@me.com

Public contact
Name of contact person Hideyuki Arita
Organization Osaka University Hospital
Division name Department of Neurosurgery
Address 2-15, Yamadaoka, Suita, Osaka 565-0871, Japan
TEL 06-6879-5111
Homepage URL
Email h-arita@nsurg.med.osaka-u.ac.jp

Sponsor
Institute Department of Neurosrugery, Osaka University Hospital
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪大学医学部付属病院(大阪府)

Other administrative information
Date of disclosure of the study information
2011 Year 05 Month 20 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 01 Month 13 Day
Anticipated trial start date
2011 Year 01 Month 13 Day
Last follow-up date
2013 Year 09 Month 01 Day
Date of closure to data entry
2013 Year 09 Month 01 Day
Date trial data considered complete
2013 Year 09 Month 01 Day
Date analysis concluded
2013 Year 09 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2011 Year 05 Month 18 Day
Last modified on
2018 Year 11 Month 22 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000006629